Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Complement and coagulation cascades (mmu04610)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
A2m
KLA  ATP  ATP+KLA
 NM_175628 alpha-2-macroglobulin (A2m), mRNA [NM_175628] KLA 1.00 1.03 1.04 .98 1.06 1.03 1.01
ATP 1.02 1.06 1.03 1.02 1.05 .98 1.02
KLA/ATP 1.02 1.01 1.05 1.06 1.07 1.04 1.01
Bdkrb1
KLA  ATP  ATP+KLA
 NM_007539 bradykinin receptor, beta 1 (Bdkrb1), mRNA [NM_007539] KLA 1.60 1.44 1.47 1.36 1.29 1.38 1.04
ATP 1.05 .99 1.17 1.12 1.15 1.16 .95
KLA/ATP 1.51 1.59 1.94 1.30 1.22 1.23 1.20
Bdkrb2
KLA  ATP  ATP+KLA
 NM_009747 bradykinin receptor, beta 2 (Bdkrb2), mRNA [NM_009747] KLA .97 .96 1.01 1.09 1.01 1.00 1.08
ATP 1.07 .98 1.04 1.01 1.05 1.00 1.08
KLA/ATP 1.02 1.05 1.04 1.01 1.03 1.04 .98
C1qa
KLA  ATP  ATP+KLA
 NM_007572 complement component 1, q subcomponent, alpha polypeptide (C1qa), mRNA [NM_007572] KLA 1.12 1.11 1.09 .94 1.11 1.12 1.31
ATP 1.14 1.21 .88 1.16 .90 .67 .95
KLA/ATP 1.12 1.23 .93 1.27 .86 .81 .91
C1qb
KLA  ATP  ATP+KLA
 NM_009777 complement component 1, q subcomponent, beta polypeptide (C1qb), mRNA [NM_009777] KLA 1.01 1.14 1.20 1.15 1.31 1.15 1.06
ATP 1.16 1.20 .84 1.27 1.02 .70 .76
KLA/ATP 1.29 1.36 .95 1.28 1.00 .97 .85
C1qc
KLA  ATP  ATP+KLA
 NM_007574 complement component 1, q subcomponent, C chain (C1qc), mRNA [NM_007574] KLA 1.03 .97 1.01 1.04 1.07 1.13 1.15
ATP 1.07 1.06 .91 .94 .77 .62 .82
KLA/ATP 1.08 1.02 .95 1.04 .76 .73 .66
C1r
KLA  ATP  ATP+KLA
 NM_023143 complement component 1, r subcomponent (C1r), mRNA [NM_023143] KLA 8.09 7.91 7.94 8.52 7.04 6.64 3.85
ATP .96 .88 1.02 .92 .86 1.28 1.82
KLA/ATP 7.33 7.67 7.74 6.90 4.82 3.90 3.88
C1s
KLA  ATP  ATP+KLA
 NM_144938 complement component 1, s subcomponent (C1s), transcript variant 1, mRNA [NM_144938] KLA 1.32 1.25 1.42 1.28 1.26 1.18 1.22
ATP 1.00 1.04 1.04 1.06 1.02 1.12 1.21
KLA/ATP 1.34 1.30 1.19 1.19 1.15 1.18 1.21
C2
KLA  ATP  ATP+KLA
 NM_013484 complement component 2 (within H-2S) (C2), mRNA [NM_013484] KLA 1.84 2.05 2.15 2.41 2.47 2.93 3.16
ATP .96 .96 1.22 1.18 1.15 1.16 1.42
KLA/ATP 1.81 2.00 2.25 1.92 1.84 2.10 2.96
C3
KLA  ATP  ATP+KLA
 NM_009778 complement component 3 (C3), mRNA [NM_009778] KLA 28.58 25.57 24.39 27.34 23.38 23.21 18.10
ATP 1.04 .93 1.21 1.90 2.80 5.74 12.19
KLA/ATP 27.04 26.10 33.29 23.09 25.65 23.77 40.22
C3ar1
KLA  ATP  ATP+KLA
 NM_009779 complement component 3a receptor 1 (C3ar1), mRNA [NM_009779] KLA .93 1.01 1.03 1.20 1.34 1.60 1.59
ATP 1.03 1.13 .81 .99 .72 .48 1.44
KLA/ATP 1.06 1.02 .77 .99 .81 .85 1.20
C4b
KLA  ATP  ATP+KLA
 NM_009780 complement component 4B (Childo blood group) (C4b), mRNA [NM_009780] KLA 1.46 1.50 1.67 1.58 1.87 1.68 1.33
ATP 1.05 .99 .95 .87 .88 .79 .66
KLA/ATP 1.39 1.62 1.52 1.32 1.36 1.03 .73
C4bp
KLA  ATP  ATP+KLA
 AK050344 adult male liver tumor cDNA, RIKEN full-length enriched library, clone:C730039N23 product:hypothetical protein, full insert sequence. [AK050344] KLA .92 .99 .98 1.00 1.02 .97 .98
ATP 1.02 1.03 .96 .99 1.02 .96 .97
KLA/ATP .99 1.03 1.04 .95 .92 .93 .96
C4bp
KLA  ATP  ATP+KLA
 NM_007576 complement component 4 binding protein (C4bp), mRNA [NM_007576] KLA 1.10 1.00 .94 .98 1.02 .97 .99
ATP .94 .98 1.05 .99 .96 .98 .99
KLA/ATP .95 .93 1.06 1.02 1.09 1.05 .96
C5ar1
KLA  ATP  ATP+KLA
 NM_007577 complement component 5a receptor 1 (C5ar1), mRNA [NM_007577] KLA 1.10 1.18 1.09 .81 .64 .49 .83
ATP 1.07 1.30 1.02 2.07 .92 .48 1.75
KLA/ATP 1.24 1.32 .83 1.58 .69 .46 .85
C6
KLA  ATP  ATP+KLA
 NM_016704 complement component 6 (C6), mRNA [NM_016704] KLA 1.04 .97 1.04 1.06 .98 1.04 .95
ATP 1.02 1.00 1.02 .96 1.01 .97 1.02
KLA/ATP .94 .95 1.07 1.05 .94 .94 .94
C8a
KLA  ATP  ATP+KLA
 NM_146148 complement component 8, alpha polypeptide (C8a), mRNA [NM_146148] KLA 1.02 1.02 .99 .96 1.06 1.03 1.01
ATP 1.05 1.10 1.00 1.00 .99 1.03 .98
KLA/ATP .98 1.00 1.02 .97 .92 .93 1.03
C8b
KLA  ATP  ATP+KLA
 NM_133882 complement component 8, beta subunit (C8b), mRNA [NM_133882] KLA .95 .96 .96 .95 1.00 .98 .98
ATP 1.07 .96 1.03 1.03 .96 .96 .90
KLA/ATP .99 1.05 1.03 .99 .96 1.03 .95
C8g
KLA  ATP  ATP+KLA
 NM_027062 complement component 8, gamma subunit (C8g), mRNA [NM_027062] KLA .89 .86 .85 .81 .74 .67 .90
ATP .94 .84 .79 .77 .63 .61 .82
KLA/ATP .85 .75 .74 .72 .62 .65 .81
C9
KLA  ATP  ATP+KLA
 NM_013485 complement component 9 (C9), mRNA [NM_013485] KLA 1.01 .95 1.00 1.03 1.01 1.05 1.07
ATP .96 .99 1.01 1.05 .98 1.04 1.06
KLA/ATP 1.00 .97 .94 1.01 1.11 1.05 1.13
Cd46
KLA  ATP  ATP+KLA
 AK047275 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930044L09 product:unclassifiable, full insert sequence [AK047275] KLA 1.14 1.04 1.06 1.07 1.06 .98 .99
ATP .98 .88 1.04 .94 .94 .96 1.04
KLA/ATP 1.05 .98 1.06 1.04 1.03 1.07 1.00
Cd46
KLA  ATP  ATP+KLA
 NM_010778 CD46 antigen, complement regulatory protein (Cd46), mRNA [NM_010778] KLA 1.05 .97 .99 .95 1.01 1.08 .99
ATP .97 .94 .95 .93 .94 1.04 1.06
KLA/ATP 1.02 .95 1.01 .98 .95 .94 1.04
Cd55
KLA  ATP  ATP+KLA
 AF143541 decay accelerating factor glycosylphoshatidylinositol-anchored form (DAF) mRNA, partial cds. [AF143541] KLA .98 1.01 1.05 1.08 .98 .99 1.03
ATP 1.01 1.00 .95 .96 1.04 1.06 1.00
KLA/ATP 1.01 .99 1.05 .97 1.03 .97 .96
Cd55
KLA  ATP  ATP+KLA
 AK030285 11 days pregnant adult female ovary and uterus cDNA, RIKEN full-length enriched library, clone:5031405O06 product:decay accelerating factor 1, full insert sequence [AK030285] KLA 1.28 1.22 1.35 1.29 1.26 1.42 2.37
ATP 1.02 .96 1.02 1.00 .92 .98 1.32
KLA/ATP 1.30 1.22 1.19 1.04 .96 1.02 1.33
Cd55
KLA  ATP  ATP+KLA
 NM_010016 CD55 antigen (Cd55), mRNA [NM_010016] KLA 1.81 1.70 1.81 1.92 2.16 2.13 4.63
ATP 1.09 1.04 1.16 1.05 1.14 1.32 1.92
KLA/ATP 1.80 1.89 1.79 1.56 1.26 1.39 3.24
Cd59a
KLA  ATP  ATP+KLA
 NM_007652 CD59a antigen (Cd59a), transcript variant 2, mRNA [NM_007652] KLA .80 .80 .76 .72 .65 .66 .75
ATP .94 .91 1.06 .99 .89 .69 1.34
KLA/ATP .78 .77 .88 .77 .71 .52 .85
Cd59b
KLA  ATP  ATP+KLA
 NM_181858 CD59b antigen (Cd59b), mRNA [NM_181858] KLA .92 .91 .92 .93 .89 .94 .88
ATP .98 1.00 1.02 1.01 .91 .92 .94
KLA/ATP .90 .91 .95 .91 .89 .86 .86
Cfb
KLA  ATP  ATP+KLA
 NM_008198 complement factor B (Cfb), mRNA [NM_008198] KLA 17.72 17.63 19.57 22.37 22.31 26.39 22.71
ATP .99 .94 1.17 1.19 1.32 7.30 13.25
KLA/ATP 16.12 18.46 25.42 23.14 22.30 25.87 31.46
Cfd
KLA  ATP  ATP+KLA
 NM_013459 complement factor D (adipsin) (Cfd), mRNA [NM_013459] KLA .97 .95 1.04 1.01 1.02 .95 1.08
ATP 1.03 1.00 1.10 1.00 .99 .95 .98
KLA/ATP 1.07 1.05 1.05 .93 .97 1.09 .93
Cfh
KLA  ATP  ATP+KLA
 M12660 gb|Mouse CFh locus, complement protein H gene, complete cds, clones MH(4,8). [M12660] KLA .84 .95 .90 .70 .58 .32 .13
ATP 1.11 1.46 1.17 1.10 .72 .44 .17
KLA/ATP .98 1.00 .86 .90 .53 .36 .14
Cfh
KLA  ATP  ATP+KLA
 NM_009888 complement component factor h (Cfh), mRNA [NM_009888] KLA .86 .82 .81 .66 .43 .21 .07
ATP 1.00 .98 1.37 .95 .65 .41 .11
KLA/ATP .83 .83 .96 .71 .46 .25 .07
Cfi
KLA  ATP  ATP+KLA
 NM_007686 complement component factor i (Cfi), mRNA [NM_007686] KLA .95 1.00 1.03 1.02 1.06 1.03 1.00
ATP .96 .94 .97 1.03 1.11 1.06 1.06
KLA/ATP 1.00 1.00 1.07 1.01 1.08 1.08 1.05
Cpb2
KLA  ATP  ATP+KLA
 AK015095 adult male testis cDNA, RIKEN full-length enriched library, clone:4930405E17 product:unclassifiable, full insert sequence. [AK015095] KLA 1.00 .93 .99 1.01 .99 1.00 .95
ATP .96 1.02 .98 .95 1.01 .98 1.01
KLA/ATP .96 .99 .92 .97 .98 1.04 1.00
Cpb2
KLA  ATP  ATP+KLA
 NM_019775 carboxypeptidase B2 (plasma) (Cpb2), mRNA [NM_019775] KLA 1.13 1.19 .95 1.16 1.03 1.01 .84
ATP .98 1.23 .91 1.00 .88 1.06 1.07
KLA/ATP 1.08 1.25 1.10 1.12 1.15 1.07 1.12
Cr1l
KLA  ATP  ATP+KLA
 AK017702 8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730478H20 product:complement receptor related protein, full insert sequence. [AK017702] KLA .94 .99 .98 .97 .99 .95 .92
ATP .93 .93 .89 .97 .92 .91 .94
KLA/ATP .94 .92 .92 .90 .93 .91 .96
Cr1l
KLA  ATP  ATP+KLA
 NM_013499 complement component (3b/4b) receptor 1-like (Cr1l), mRNA [NM_013499] KLA 2.09 2.17 2.05 1.93 1.88 1.40 1.06
ATP 1.03 1.12 1.23 1.26 1.05 1.10 1.32
KLA/ATP 1.89 2.32 2.49 2.58 1.69 1.23 1.38
Cr2
KLA  ATP  ATP+KLA
 NM_007758 complement receptor 2 (Cr2), mRNA [NM_007758] KLA .98 .98 .99 1.01 1.00 .99 1.02
ATP 1.03 .99 .94 1.01 1.02 .95 .99
KLA/ATP 1.04 1.07 1.07 1.08 1.06 1.04 .93
Daf2
KLA  ATP  ATP+KLA
 AK019553 adult male testis cDNA, RIKEN full-length enriched library, clone:4921540H11 product:decay accelerating factor 2, full insert sequence. [AK019553] KLA 1.04 .91 .97 .98 1.02 1.02 .95
ATP .97 1.03 .91 .96 .95 1.05 1.05
KLA/ATP .94 .99 1.00 1.00 .99 .97 1.02
Daf2
KLA  ATP  ATP+KLA
 NM_007827 decay accelerating factor 2 (Daf2), mRNA [NM_007827] KLA 1.06 .99 1.00 1.00 1.03 1.04 1.18
ATP 1.03 1.03 .93 1.05 .97 .85 .98
KLA/ATP 1.11 1.13 1.10 1.00 .93 1.05 1.02
EG317677
KLA  ATP  ATP+KLA
 NM_173864 predicted gene, EG317677 (EG317677), mRNA [NM_173864] KLA .99 .99 1.01 1.01 .97 .98 1.06
ATP 1.00 1.01 1.05 1.05 .98 .99 1.01
KLA/ATP 1.00 1.00 .99 1.02 1.01 1.01 1.02
F10
KLA  ATP  ATP+KLA
 NM_007972 coagulation factor X (F10), mRNA [NM_007972] KLA 5.86 5.87 6.54 8.71 10.60 8.36 11.34
ATP 1.07 .92 1.06 2.99 6.34 10.26 11.43
KLA/ATP 5.93 6.64 7.57 11.71 14.66 15.63 22.03
F11
KLA  ATP  ATP+KLA
 NM_028066 coagulation factor XI (F11), mRNA [NM_028066] KLA 1.01 .99 .98 1.03 1.02 1.13 1.02
ATP .95 .97 .98 1.01 1.08 1.15 1.04
KLA/ATP .96 .96 1.09 1.00 1.75 1.98 1.33
F12
KLA  ATP  ATP+KLA
 NM_021489 coagulation factor XII (Hageman factor) (F12), mRNA [NM_021489] KLA 1.00 .97 1.06 .89 .97 .99 1.04
ATP 1.00 1.02 1.06 1.06 1.01 1.05 1.03
KLA/ATP 1.01 .99 .91 .97 .92 .97 .94
F13a1
KLA  ATP  ATP+KLA
 NM_028784 coagulation factor XIII, A1 subunit (F13a1), mRNA [NM_028784] KLA .97 1.12 1.01 1.00 .97 .86 .21
ATP .99 1.14 1.29 1.42 1.45 2.04 .39
KLA/ATP .92 1.02 1.12 1.29 1.04 .79 .24
F13b
KLA  ATP  ATP+KLA
 NM_031164 coagulation factor XIII, beta subunit (F13b), mRNA [NM_031164] KLA 1.02 1.01 1.06 1.01 1.06 1.07 .98
ATP .97 1.03 1.02 .97 1.02 1.02 .96
KLA/ATP .92 1.03 1.03 1.04 .98 .94 .94
F2
KLA  ATP  ATP+KLA
 NM_010168 coagulation factor II (F2), mRNA [NM_010168] KLA .99 .92 .95 1.01 1.01 1.06 .97
ATP 1.03 1.02 1.04 1.07 1.08 .96 .99
KLA/ATP .95 1.04 1.02 1.02 1.04 1.07 .99
F2r
KLA  ATP  ATP+KLA
 NM_010169 coagulation factor II (thrombin) receptor (F2r), mRNA [NM_010169] KLA 3.73 3.81 3.68 3.00 2.75 1.49 1.01
ATP .98 1.02 1.25 1.24 1.31 1.63 1.16
KLA/ATP 3.51 4.05 3.49 3.00 2.48 1.69 1.23
F3
KLA  ATP  ATP+KLA
 NM_010171 coagulation factor III (F3), mRNA [NM_010171] KLA 3.09 3.39 2.45 1.45 .96 .89 .92
ATP 1.15 1.35 2.83 8.34 4.90 2.03 1.10
KLA/ATP 4.01 4.37 4.26 5.95 2.62 1.65 1.13
F5
KLA  ATP  ATP+KLA
 NM_007976 coagulation factor V (F5), mRNA [NM_007976] KLA 1.05 .96 1.03 1.00 .97 1.07 1.04
ATP 1.00 1.00 1.08 1.04 1.03 1.07 1.03
KLA/ATP 1.04 .96 .85 .99 1.03 1.09 .96
F7
KLA  ATP  ATP+KLA
 NM_010172 coagulation factor VII (F7), mRNA [NM_010172] KLA 1.39 1.73 1.71 1.78 2.13 2.20 2.38
ATP 1.05 1.02 1.05 1.14 1.11 1.39 3.04
KLA/ATP 1.61 1.53 1.54 1.77 1.65 1.99 4.87
F8
KLA  ATP  ATP+KLA
 NM_007977 coagulation factor VIII (F8), mRNA [NM_007977] KLA 1.15 1.20 1.36 1.41 1.41 1.63 1.23
ATP 1.03 1.06 1.01 .97 .93 .86 .87
KLA/ATP 1.18 1.25 1.29 1.18 1.20 1.19 1.12
F9
KLA  ATP  ATP+KLA
 NM_007979 coagulation factor IX (F9), mRNA [NM_007979] KLA 1.14 1.14 1.15 1.17 1.18 1.15 1.10
ATP 1.01 1.01 1.06 1.00 .96 .99 .96
KLA/ATP 1.16 1.21 1.18 1.15 1.08 .98 1.02
Fga
KLA  ATP  ATP+KLA
 NM_010196 fibrinogen, alpha polypeptide (Fga), transcript variant 2, mRNA [NM_010196] KLA 1.00 1.08 1.01 .99 1.00 1.03 .94
ATP 1.00 1.04 1.05 .94 .98 1.03 1.07
KLA/ATP .97 1.03 1.05 1.00 .96 .93 1.04
Fgb
KLA  ATP  ATP+KLA
 NM_181849 fibrinogen, B beta polypeptide (Fgb), mRNA [NM_181849] KLA .98 1.03 1.09 1.12 1.05 1.13 1.10
ATP .98 1.02 1.01 .99 1.10 1.02 .99
KLA/ATP 1.02 1.03 1.03 1.12 1.07 1.15 1.02
Fgg
KLA  ATP  ATP+KLA
 NM_133862 fibrinogen, gamma polypeptide (Fgg), mRNA [NM_133862] KLA 1.01 1.00 .96 1.02 .99 1.01 1.07
ATP .97 .94 1.00 1.03 1.00 1.08 1.08
KLA/ATP .96 1.00 .98 1.01 .98 1.06 1.01
Hc
KLA  ATP  ATP+KLA
 NM_010406 hemolytic complement (Hc), mRNA [NM_010406] KLA 1.07 1.12 1.05 .98 1.12 1.12 1.08
ATP .96 .93 1.12 1.07 1.34 5.60 1.48
KLA/ATP 1.05 1.18 1.12 1.05 1.13 3.40 4.37
Klkb1
KLA  ATP  ATP+KLA
 NM_008455 kallikrein B, plasma 1 (Klkb1), mRNA [NM_008455] KLA .97 1.00 1.01 1.04 1.06 1.14 1.11
ATP 1.05 .99 1.05 1.16 1.27 1.13 1.08
KLA/ATP .99 1.03 1.02 1.16 1.60 1.29 1.29
Kng1
KLA  ATP  ATP+KLA
 NM_023125 kininogen 1 (Kng1), transcript variant 2, mRNA [NM_023125] KLA 1.01 1.00 1.03 1.01 1.02 1.02 1.02
ATP 1.04 1.02 1.01 1.01 1.01 1.03 1.06
KLA/ATP 1.05 .99 1.06 1.00 1.00 1.03 .99
Kng2
KLA  ATP  ATP+KLA
 NM_201375 kininogen 2 (Kng2), transcript variant 1, mRNA [NM_201375] KLA 1.11 1.10 1.07 1.01 .96 1.03 .96
ATP 1.02 1.04 1.00 .97 .91 .96 1.02
KLA/ATP .97 .99 1.03 1.02 .98 .94 .97
Masp1
KLA  ATP  ATP+KLA
 AK031598 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030458D19 product:mannan-binding lectin serine protease 1, full insert sequence. [AK031598] KLA .98 .96 1.11 1.00 1.10 1.12 1.12
ATP 1.02 1.01 .99 .97 .99 1.05 1.40
KLA/ATP .96 .93 1.04 1.00 1.04 1.41 1.93
Masp1
KLA  ATP  ATP+KLA
 NM_008555 mannan-binding lectin serine peptidase 1 (Masp1), mRNA [NM_008555] KLA 1.02 1.05 1.01 1.00 .98 1.04 .96
ATP 1.04 .98 .92 1.06 .98 .93 .98
KLA/ATP 1.04 1.06 1.01 .98 1.06 .96 1.04
Masp2
KLA  ATP  ATP+KLA
 NM_001003893 mannan-binding lectin serine peptidase 2 (Masp2), transcript variant 1, mRNA [NM_001003893] KLA 1.01 .97 .99 .94 1.00 .93 1.00
ATP .99 .93 .98 1.01 .96 .90 1.06
KLA/ATP .92 1.00 .99 .98 .99 .97 .97
Masp2
KLA  ATP  ATP+KLA
 NM_010767 mannan-binding lectin serine peptidase 2 (Masp2), transcript variant 2, mRNA [NM_010767] KLA .71 .71 .68 .65 .64 .63 .59
ATP 1.02 1.10 .94 .98 .73 .70 .70
KLA/ATP .73 .68 .67 .72 .65 .59 .65
Mbl1
KLA  ATP  ATP+KLA
 NM_010775 mannose binding lectin (A) (Mbl1), mRNA [NM_010775] KLA .97 1.06 .97 1.03 1.02 .99 .98
ATP 1.05 1.03 .95 1.00 .97 .93 .98
KLA/ATP 1.12 1.00 1.07 1.04 .92 1.02 .94
Mbl2
KLA  ATP  ATP+KLA
 NM_010776 mannose binding lectin (C) (Mbl2), mRNA [NM_010776] KLA 1.04 1.00 1.02 .96 .97 1.00 .96
ATP .98 1.00 .98 .93 .97 .93 .98
KLA/ATP 1.04 1.06 .99 .98 1.02 .94 1.05
Mm.1805
KLA  ATP  ATP+KLA
 6679732 Unknown KLA 1.38 1.48 1.79 2.27 2.12 2.48 1.81
ATP 1.02 .94 1.09 1.10 .94 .96 .97
KLA/ATP 1.47 1.59 1.66 1.55 1.55 1.61 1.50
Mm.19763
8
KLA  ATP  ATP+KLA
 22122666 Unknown KLA .93 1.02 .99 .99 1.03 1.02 1.04
ATP 1.01 1.00 1.05 .88 .98 .98 1.01
KLA/ATP 1.03 1.01 1.00 .97 1.00 1.07 .96
Mm.2408
KLA  ATP  ATP+KLA
 147904678 Unknown KLA .92 .85 1.02 1.30 1.31 1.65 1.62
ATP .92 .87 .90 .60 .44 .36 1.61
KLA/ATP .87 .78 .82 .60 .66 .59 1.06
Mm.44041
4
KLA  ATP  ATP+KLA
 156231028 Unknown KLA 1.00 1.00 1.07 .93 .97 1.04 .94
ATP 1.02 1.00 .91 .98 1.01 1.06 1.00
KLA/ATP .96 .98 .98 1.02 1.00 .91 1.06
Plat
KLA  ATP  ATP+KLA
 AK053476 0 day neonate eyeball cDNA, RIKEN full-length enriched library, clone:E130020K19 product:plasminogen activator, tissue, full insert sequence [AK053476] KLA 1.06 1.02 1.06 .99 1.11 .97 1.03
ATP .93 1.10 1.82 4.69 1.17 1.06 1.10
KLA/ATP 1.02 .99 1.38 1.87 1.09 1.03 1.01
Plat
KLA  ATP  ATP+KLA
 NM_008872 plasminogen activator, tissue (Plat), mRNA [NM_008872] KLA 3.87 3.94 2.80 2.09 1.92 1.41 1.20
ATP 1.08 1.07 2.42 10.85 8.51 3.53 1.28
KLA/ATP 3.87 4.26 3.93 7.51 5.17 4.48 1.90
Plau
KLA  ATP  ATP+KLA
 NM_008873 plasminogen activator, urokinase (Plau), mRNA [NM_008873] KLA .28 .27 .22 .23 .19 .25 .27
ATP .99 1.19 1.63 2.44 1.52 .49 1.12
KLA/ATP .26 .29 .32 .40 .35 .32 .48
Plaur
KLA  ATP  ATP+KLA
 NM_011113 plasminogen activator, urokinase receptor (Plaur), mRNA [NM_011113] KLA 2.40 2.61 2.30 1.95 1.60 .80 .47
ATP 1.08 1.28 1.24 2.13 2.75 4.78 2.70
KLA/ATP 2.66 3.04 2.56 3.92 2.64 3.10 2.81
Plg
KLA  ATP  ATP+KLA
 NM_008877 plasminogen (Plg), mRNA [NM_008877] KLA 1.02 1.05 1.06 1.02 1.01 1.09 1.07
ATP .99 .96 1.07 1.08 1.02 .95 1.09
KLA/ATP 1.09 .98 .98 1.09 1.21 1.08 1.04
Proc
KLA  ATP  ATP+KLA
 NM_001042768 protein C (Proc), transcript variant 3, mRNA [NM_001042768] KLA 1.05 1.06 1.08 1.04 1.11 .72 1.07
ATP 1.01 .97 1.09 1.05 1.00 1.08 1.06
KLA/ATP 1.09 1.08 1.15 1.08 1.20 1.11 1.21
Pros1
KLA  ATP  ATP+KLA
 NM_011173 protein S (alpha) (Pros1), mRNA [NM_011173] KLA 1.28 1.31 1.48 1.32 1.06 .69 .35
ATP .99 1.01 1.09 1.08 .89 .79 .28
KLA/ATP 1.24 1.31 1.43 1.28 1.04 .71 .23
Serpina1
b
KLA  ATP  ATP+KLA
 BC037008 serine (or cysteine) preptidase inhibitor, clade A, member 1b, mRNA (cDNA clone IMAGE:5125410). [BC037008] KLA 1.02 1.02 1.02 1.01 1.08 .99 1.03
ATP .94 1.03 .93 1.04 1.03 .99 .94
KLA/ATP 1.07 .96 .98 1.05 1.08 1.03 .99
Serpina1
c
KLA  ATP  ATP+KLA
 NM_009245 serine (or cysteine) peptidase inhibitor, clade A, member 1c (Serpina1c), mRNA [NM_009245] KLA 1.03 1.02 1.03 1.03 .95 .99 .99
ATP .95 1.08 1.13 1.00 .95 1.07 1.10
KLA/ATP .99 .95 1.13 .99 1.01 .90 1.03
Serpina1
d
KLA  ATP  ATP+KLA
 NM_009246 serine (or cysteine) peptidase inhibitor, clade A, member 1d (Serpina1d), mRNA [NM_009246] KLA 1.01 1.01 .98 1.00 .96 .96 .93
ATP 1.02 .99 .99 .96 .94 .96 .89
KLA/ATP .93 1.00 1.01 .93 .97 .88 .94
Serpina5
KLA  ATP  ATP+KLA
 NM_172953 serine (or cysteine) peptidase inhibitor, clade A, member 5 (Serpina5), mRNA [NM_172953] KLA .99 1.03 1.03 .97 1.01 1.01 1.05
ATP 1.02 1.04 .98 1.00 .99 1.03 1.00
KLA/ATP 1.03 1.05 1.03 1.02 .95 .98 1.00
Serpinc1
KLA  ATP  ATP+KLA
 NM_080844 serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 (Serpinc1), mRNA [NM_080844] KLA 1.12 1.22 1.22 1.24 1.17 1.12 1.04
ATP .97 1.00 1.18 1.25 1.30 1.51 1.09
KLA/ATP 1.22 1.17 1.22 1.26 1.45 1.70 1.32
Serpind1
KLA  ATP  ATP+KLA
 NM_008223 serine (or cysteine) peptidase inhibitor, clade D, member 1 (Serpind1), mRNA [NM_008223] KLA .96 1.00 .96 1.02 1.10 1.03 1.00
ATP 1.01 1.08 1.07 .97 1.04 1.14 1.10
KLA/ATP .95 1.00 1.03 1.01 1.06 .99 1.06
Serpine1
KLA  ATP  ATP+KLA
 AK040662 adult male aorta and vein cDNA, RIKEN full-length enriched library, clone:A530009B11 product:serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1, full insert sequence. [AK040662] KLA 1.12 1.08 1.10 1.03 1.00 1.01 1.05
ATP 1.00 1.09 1.39 1.44 1.05 .95 .99
KLA/ATP 1.09 1.10 1.02 1.03 1.08 1.19 1.02
Serpine1
KLA  ATP  ATP+KLA
 NM_008871 serine (or cysteine) peptidase inhibitor, clade E, member 1 (Serpine1), mRNA [NM_008871] KLA 36.00 31.05 27.47 23.20 11.59 4.14 1.47
ATP .97 1.15 3.43 11.58 8.77 7.42 2.16
KLA/ATP 31.47 33.70 38.54 30.90 22.06 23.68 18.57
Serpinf2
KLA  ATP  ATP+KLA
 NM_008878 serine (or cysteine) peptidase inhibitor, clade F, member 2 (Serpinf2), mRNA [NM_008878] KLA .98 .99 1.00 1.03 1.04 1.05 1.03
ATP 1.06 1.09 1.17 2.30 2.35 1.48 1.02
KLA/ATP 1.02 1.04 1.03 1.39 2.59 1.51 1.27
Serping1
KLA  ATP  ATP+KLA
 NM_009776 serine (or cysteine) peptidase inhibitor, clade G, member 1 (Serping1), mRNA [NM_009776] KLA 1.45 1.45 1.79 1.55 1.71 1.50 1.27
ATP .98 1.05 1.09 .99 1.06 1.05 1.03
KLA/ATP 1.59 1.55 1.62 1.60 1.51 1.23 1.39
Tfpi
KLA  ATP  ATP+KLA
 NM_011576 tissue factor pathway inhibitor (Tfpi), mRNA [NM_011576] KLA 1.09 1.10 1.12 .91 .96 .90 .94
ATP .95 .97 1.20 1.07 1.01 1.20 1.05
KLA/ATP .99 1.12 1.28 1.02 .96 1.14 .97
Thbd
KLA  ATP  ATP+KLA
 NM_009378 thrombomodulin (Thbd), mRNA [NM_009378] KLA .14 .12 .20 .24 .23 .25 .34
ATP 1.01 1.14 2.33 1.84 6.23 4.56 1.44
KLA/ATP .12 .11 .23 .36 3.44 1.73 .52
Vwf
KLA  ATP  ATP+KLA
 AK044921 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130011O06 product:VON WILLEBRAND FACTOR (FRAGMENT) homolog [Saguinus bicolor], full insert sequence. [AK044921] KLA 1.02 .96 .97 .95 .97 1.00 .91
ATP 1.01 1.03 .93 1.02 1.01 1.00 1.08
KLA/ATP .99 .93 .99 .96 1.02 1.01 1.08
Vwf
KLA  ATP  ATP+KLA
 NM_011708 Von Willebrand factor homolog (Vwf), mRNA [NM_011708] KLA .56 .56 .51 .41 .37 .50 .33
ATP 1.09 .99 .77 .88 3.26 2.28 .64
KLA/ATP .65 .58 .46 .52 2.61 3.48 1.38
Zp3r
KLA  ATP  ATP+KLA
 NM_009581 zona pellucida 3 receptor (Zp3r), mRNA [NM_009581] KLA 1.00 1.07 1.02 1.08 1.07 1.11 1.02
ATP .96 1.09 .98 1.14 1.01 1.00 .96
KLA/ATP 1.07 1.00 .94 1.02 .99 .99 1.00